Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 31 04:00PM ET
1.81
Dollar change
-0.03
Percentage change
-1.63
%
IndexRUT P/E- EPS (ttm)-3.39 Insider Own63.18% Shs Outstand47.67M Perf Week-0.55%
Market Cap90.11M Forward P/E- EPS next Y-1.73 Insider Trans-0.08% Shs Float18.33M Perf Month0.56%
Income-156.27M PEG- EPS next Q-0.42 Inst Own47.20% Short Float6.85% Perf Quarter6.47%
Sales0.00M P/S- EPS this Y18.93% Inst Trans31.29% Short Ratio3.87 Perf Half Y-87.09%
Book/sh4.16 P/B0.44 EPS next Y29.98% ROA-55.47% Short Interest1.26M Perf Year-83.55%
Cash/sh4.92 P/C0.37 EPS next 5Y- ROE-73.77% 52W Range1.55 - 20.22 Perf YTD-88.72%
Dividend Est.- P/FCF- EPS past 5Y-241.80% ROI-68.90% 52W High-91.05% Beta0.79
Dividend TTM- Quick Ratio5.14 Sales past 5Y0.00% Gross Margin- 52W Low16.77% ATR (14)0.07
Dividend Ex-Date- Current Ratio5.14 EPS Y/Y TTM-37.60% Oper. Margin0.00% RSI (14)46.26 Volatility3.70% 3.25%
Employees90 Debt/Eq0.25 Sales Y/Y TTM- Profit Margin- Recom3.00 Target Price3.33
Option/ShortNo / Yes LT Debt/Eq0.11 EPS Q/Q-12.47% Payout- Rel Volume0.22 Prev Close1.84
Sales Surprise- EPS Surprise-6.22% Sales Q/Q- EarningsAug 08 AMC Avg Volume324.09K Price1.81
SMA20-0.47% SMA50-0.23% SMA200-80.76% Trades Volume70,051 Change-1.63%
Date Action Analyst Rating Change Price Target Change
Jul-09-24Downgrade Stifel Buy → Hold $34 → $3
Jul-09-24Downgrade Leerink Partners Outperform → Market Perform $28 → $2
Jul-09-24Downgrade H.C. Wainwright Buy → Neutral $28 → $2
Jul-08-24Downgrade JP Morgan Overweight → Neutral $24 → $5
Jul-08-24Downgrade Guggenheim Buy → Neutral
Dec-13-23Initiated H.C. Wainwright Buy $28
Oct-14-24 12:00PM
Aug-08-24 07:20PM
Aug-01-24 11:53AM
Jul-31-24 04:00PM
Jul-29-24 09:35AM
09:35AM Loading…
Jul-11-24 09:35AM
Jul-09-24 10:19AM
Jul-08-24 12:36PM
12:17PM
08:42AM
08:16AM
07:30AM
May-23-24 02:15AM
May-10-24 02:26PM
May-09-24 11:55PM
04:05PM Loading…
04:05PM
Apr-14-24 12:52PM
Apr-06-24 01:33AM
Mar-21-24 02:32AM
Mar-20-24 09:53PM
04:00PM
Mar-08-24 11:55PM
Feb-22-24 11:27PM
Feb-05-24 04:05PM
Jan-18-24 07:00AM
Jan-08-24 07:00AM
Jan-03-24 06:28PM
Dec-19-23 01:01PM
Dec-05-23 09:48PM
Nov-30-23 09:55AM
11:03AM Loading…
Nov-21-23 11:03AM
Nov-14-23 12:00PM
09:55AM
Nov-09-23 04:05PM
Nov-01-23 04:48PM
Sep-26-23 04:01PM
Sep-25-23 07:00AM
Sep-19-23 08:05PM
04:09PM
Aug-24-23 10:40AM
Aug-14-23 05:08PM
07:00AM
Jun-07-23 09:55AM
May-22-23 09:55AM
May-12-23 04:05PM
May-09-23 07:00AM
Apr-25-23 06:45AM
HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kohli AdityaDirectorMay 20 '24Sale15.456,00092,689776,878May 22 05:40 PM
Kohli AdityaDirectorMay 22 '24Sale14.736,00088,372764,878May 22 05:40 PM
Kohli AdityaDirectorMay 21 '24Sale14.216,00085,230770,878May 22 05:40 PM
Kohli AdityaDirectorMay 02 '24Sale14.016,00084,081783,601May 03 07:12 PM
Kohli AdityaDirectorMay 03 '24Sale14.1572310,233782,878May 03 07:12 PM
Kohli AdityaDirectorMay 01 '24Sale14.031752,456789,601May 03 07:12 PM
Frazier Life Sciences X, L.P.10% OwnerApr 04 '24Buy14.508,850128,3258,544,187Apr 08 04:22 PM
Kohli AdityaDirectorApr 03 '24Sale14.936,00089,582801,776Apr 05 05:48 PM
Kohli AdityaDirectorApr 04 '24Sale14.716,00088,245795,776Apr 05 05:48 PM
Kohli AdityaDirectorApr 05 '24Sale14.446,00086,640789,776Apr 05 05:48 PM
McLoughlin SeanChief Operating OfficerMar 28 '24Buy16.981,25021,2251,250Apr 01 04:08 PM
Kohli AdityaDirectorMar 18 '24Sale17.666,000105,937819,776Mar 20 06:27 PM
Kohli AdityaDirectorMar 19 '24Sale17.426,000104,492813,776Mar 20 06:27 PM
Kohli AdityaDirectorMar 20 '24Sale16.426,00098,533807,776Mar 20 06:27 PM
Kohli AdityaDirectorMar 06 '24Sale18.956,000113,701837,776Mar 08 06:38 PM
Kohli AdityaDirectorMar 08 '24Sale18.666,000111,959825,776Mar 08 06:38 PM
Kohli AdityaDirectorMar 07 '24Sale18.376,000110,213831,776Mar 08 06:38 PM
Kohli AdityaDirectorFeb 22 '24Sale15.056,00090,312843,776Feb 22 05:20 PM
Kohli AdityaDirectorFeb 21 '24Sale14.926,00089,495849,776Feb 22 05:20 PM
Kohli AdityaDirectorFeb 20 '24Sale14.886,00089,272855,776Feb 22 05:20 PM
Kohli AdityaDirectorFeb 12 '24Sale15.326,00091,921861,776Feb 14 04:22 PM
Kohli AdityaDirectorFeb 08 '24Sale14.938,866132,383812,878Feb 12 08:06 PM
Maltbie ShaneChief Financial OfficerFeb 08 '24Sale14.933,57653,39540,656Feb 12 07:51 PM
HERSHBERG ROBERTSee RemarksFeb 08 '24Sale14.9311,597173,161953,831Feb 12 07:47 PM
Borkowski AstridChief Medical OfficerFeb 08 '24Sale14.933,93358,726161,260Feb 12 07:35 PM
Borkowski AstridChief Medical OfficerDec 15 '23Sale15.5010,000155,000165,193Dec 18 05:34 PM
Borkowski AstridChief Medical OfficerDec 04 '23Sale14.5010,000145,000175,193Dec 05 04:52 PM
Borkowski AstridChief Medical OfficerDec 01 '23Sale14.2010,000142,000185,193Dec 05 04:52 PM
Borkowski AstridChief Medical OfficerNov 17 '23Sale14.0010,000140,000195,193Nov 20 04:53 PM
Borkowski AstridChief Medical OfficerNov 08 '23Sale13.005,00065,000205,193Nov 13 05:25 PM